Health-Related Quality of Life and Sleep Quality after 12 Months of Treatment in Nonsevere Obstructive Sleep Apnea: A Randomized Clinical Trial with Continuous Positive Airway Pressure and Mandibular Advancement Splints

Table 5

Number of patients with improved SF36 scores according to RCI (>1.96) and PSQI global score according to RCI (<−1.96), compliant patients only.

	Significantly improved HRQoL or sleep quality
	CPAP (n = 18)	MAS (n = 36)
Physical functioning	11.1% (2/18)	11.1% (4/36)	1.00^F
Role-physical	5.6% (1/18)	13.9% (5/36)	0.65^F
Bodily pain	5.6% (1/18)	11.1% (4/36)	0.66^F
General health	27.8% (5/18)	36.1% (13/36)	0.54
Vitality	38.9% (7/18)	50.0% (18/36)	0.44
Social functioning	5.6% (1/18)	19.4% (7/36)	0.26^F
Role-emotional	11.1% (2/18)	13.9% (5/36)	1.00^F
Mental health	16.7% (3/18)	25.0% (9/36)	0.73^F
Physical component	5.6% (1/18)	11.1% (4/36)	0.66
Mental component	22.2% (4/18)	22.2% (8/36)	1.00^F
PSQI global score	16.7% (3/18)	33.3% (12/36)	0.20

HRQoL: health-related quality of life; RCI: reliable change index; PSQI: Pittsburgh Sleep Quality Index (global score); SF36: Short Form 36 (8 domains + 2 aggregated scales); CPAP: continuous positive airway pressure; MAS: mandibular advancement splint; P: Pearson chi-square test; F: Fisher’s exact test. Significant correlation to PSQI global score.